SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Quick Heal Technologies Ltd

BSE: 539678 NSE: QUICKHEAL ISIN: INE306L01010
  |   Sector:  IT & ITES   |   Industry:  IT - Software

Snapshot

Q.1 Which industry/sub-sector does Quick Heal Technologies Ltd belong to?
Quick Heal Technologies Ltd belongs to the IT & ITES sector, operating specifically within the IT - Software segment.
Q.2 Is Quick Heal Technologies Ltd a good quality company?
Quick Heal Technologies Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Quick Heal Technologies Ltd undervalued or overvalued?
Quick Heal Technologies Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Quick Heal Technologies Ltd a good buy now?
Quick Heal Technologies Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd revenue growth is -4.2% for FY-2025 , which is below its 5 year CAGR of -0.5% , indicating slower growth.
Q.2 Gross Profit margin of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Gross profit margin which is the profit after deduction of direct costs, is 5% for FY-2025 , which is below its 5 year median of 13.3% , indicating decreasing margins.
Q.3 Operating Profit Margin of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -2.36% for FY-2025 , which is below its 5 year median of 6.07% indicating decreasing margins.
Q.4 Net Profit Margin of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Net Profit Margin is 1.8% for FY-2025 , is below with its 5 year median of 8.31%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 5 13.3
Operating Profit Margin -2.36 6.07
Net Profit Margin 1.8 8.31
Q.5 Return on Asset of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Return on Asset is 0.98%, which is below its 5 year historical median of 4.84%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Return on equity is 1.18% for FY-2025 , which is below its historical median of 5.79%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Return on capital employed is 0.28% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Cash conversion cycle is 139 days, above its historical median of 88 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.54 0.46
ROE 1.18 5.79
ROCE 0.28 6.15
Cash Conversion Cycle 139 days 88 days
Q.9 Debt to Equity ratio of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.01 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd Debt to cash flow from operations is 0 , which is at a healthy level, indicating the business is able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Quick Heal Technologies Ltd?
Promoters hold 71.54% of the Quick Heal Technologies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Quick Heal Technologies Ltd vs industry peers?
Quick Heal Technologies Ltd revenue CAGR is -0.47% , compared to the industry median CAGR of 2.48% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 279.5 23.6
Gross Profit 14 1.9
Operating Profit -7 1.2
Net Profit 5 0.8
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.54 0.45
ROE 1.18 4.09
ROCE 0.28 6.4
Cash Conversion Cycle (days) 139.24 36

Valuation & price assessment

Q.1 Stock return of Quick Heal Technologies Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -3% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price -3% -2.7% 2.7% -41%
Q.3 Valuation ratios of Quick Heal Technologies Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 153.6 9.88 22.96
Price to Book 1.95 1.30 2.61
Price to Sales 3.19 2.87 4.40
EV to EBITDA 54.36 5.60 17.20

Check more companies

1. Tata Elxsi
2. Tata Technologies
3. KPIT Technologies
4. Fractal Analytics
5. Zensar Technologies
6. Birlasoft
7. Cyient
8. Nazara Technologies
9. Intellect Design
10. Amagi Media Labs
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×